These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 29464197)
1. MeCP2 Deficiency Leads to Loss of Glial Kir4.1. Kahanovitch U; Cuddapah VA; Pacheco NL; Holt LM; Mulkey DK; Percy AK; Olsen ML eNeuro; 2018; 5(1):. PubMed ID: 29464197 [TBL] [Abstract][Full Text] [Related]
2. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related]
3. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome. Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851 [TBL] [Abstract][Full Text] [Related]
4. The disruption of central CO2 chemosensitivity in a mouse model of Rett syndrome. Zhang X; Su J; Cui N; Gai H; Wu Z; Jiang C Am J Physiol Cell Physiol; 2011 Sep; 301(3):C729-38. PubMed ID: 21307341 [TBL] [Abstract][Full Text] [Related]
5. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. Maezawa I; Swanberg S; Harvey D; LaSalle JM; Jin LW J Neurosci; 2009 Apr; 29(16):5051-61. PubMed ID: 19386901 [TBL] [Abstract][Full Text] [Related]
6. Altered microtubule dynamics and vesicular transport in mouse and human MeCP2-deficient astrocytes. Delépine C; Meziane H; Nectoux J; Opitz M; Smith AB; Ballatore C; Saillour Y; Bennaceur-Griscelli A; Chang Q; Williams EC; Dahan M; Duboin A; Billuart P; Herault Y; Bienvenu T Hum Mol Genet; 2016 Jan; 25(1):146-57. PubMed ID: 26604147 [TBL] [Abstract][Full Text] [Related]
8. An Astrocytic Influence on Impaired Tonic Inhibition in Hippocampal CA1 Pyramidal Neurons in a Mouse Model of Rett Syndrome. Dong Q; Kim J; Nguyen L; Bu Q; Chang Q J Neurosci; 2020 Aug; 40(32):6250-6261. PubMed ID: 32616668 [TBL] [Abstract][Full Text] [Related]
9. Regulation mechanism and research progress of MeCP2 in Rett syndrome. Yang W; Pan H Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025 [TBL] [Abstract][Full Text] [Related]
10. Analysis of Astroglial Secretomic Profile in the Mecp2-Deficient Male Mouse Model of Rett Syndrome. Ehinger Y; Matagne V; Cunin V; Borloz E; Seve M; Bourgoin-Voillard S; Borges-Correia A; Villard L; Roux JC Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919253 [TBL] [Abstract][Full Text] [Related]
11. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome. Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage. Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H Mol Brain; 2015 May; 8():31. PubMed ID: 26012557 [TBL] [Abstract][Full Text] [Related]
13. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation. Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495 [TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid increased MeCP2 mediated mitochondrial respiratory complexes II and III enzyme activities in cortical astrocytes. Dave A; Pillai PP J Biochem Mol Toxicol; 2022 Apr; 36(4):e23002. PubMed ID: 35174922 [TBL] [Abstract][Full Text] [Related]
15. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282 [TBL] [Abstract][Full Text] [Related]
16. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Gadalla KK; Bailey ME; Cobb SR Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843 [TBL] [Abstract][Full Text] [Related]
17. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease. Pejhan S; Rastegar M Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932 [TBL] [Abstract][Full Text] [Related]
18. Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome. Kahanovitch U; Patterson KC; Hernandez R; Olsen ML Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387202 [TBL] [Abstract][Full Text] [Related]
19. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881 [TBL] [Abstract][Full Text] [Related]
20. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]